Toward Practical Integration of Omic and Imaging Data in Co-Clinical Trials

por Alkim, Emel, Dowst, Heidi, DiCarlo, Julie, Dobrolecki, Lacey E., Hernández-Herrera, Anadulce, Hormuth, David A., Liao, Yuxing, McOwiti, Apollo, Pautler, Robia, Rimawi, Mothaffar, Roark, Ashley, Srinivasan, Ramakrishnan Rajaram, Virostko, Jack, Zhang, Bing, Zheng, Fei, Rubin, Daniel L., Yankeelov, Thomas E., Lewis, Michael T.
Publicado 2023

Integrated Analyses of microRNAs Demonstrate Their Widespread Influence on Gene Expression in High-Grade Serous Ovarian Carcinoma

por Creighton, Chad J., Hernandez-Herrera, Anadulce, Jacobsen, Anders, Levine, Douglas A., Mankoo, Parminder, Schultz, Nikolaus, Du, Ying, Zhang, Yiqun, Larsson, Erik, Sheridan, Robert, Xiao, Weimin, Spellman, Paul T., Getz, Gad, Wheeler, David A., Perou, Charles M., Gibbs, Richard A., Sander, Chris, Hayes, D. Neil, Gunaratne, Preethi H.
Publicado 2012

Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53‐altered tumors

por Gunaratne, Preethi H., Pan, Yinghong, Rao, Abhi K., Lin, Chunru, Hernandez‐Herrera, Anadulce, Liang, Ke, Rait, Antonina S., Venkatanarayan, Avinashnarayan, Benham, Ashley L., Rubab, Farwah, Kim, Sang Soo, Rajapakshe, Kimal, Chan, Clara K., Mangala, Lingegowda S., Lopez‐Berestein, Gabriel, Sood, Anil K., Rowat, Amy C., Coarfa, Cristian, Pirollo, Kathleen F., Flores, Elsa R., Chang, Esther H.
Publicado 2019

miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer

por Pan, Yinghong, Robertson, Gordon, Pedersen, Lykke, Lim, Emilia, Hernandez-Herrera, Anadulce, Rowat, Amy C., Patil, Sagar L., Chan, Clara K., Wen, Yunfei, Zhang, Xinna, Basu-Roy, Upal, Mansukhani, Alka, Chu, Andy, Sipahimalani, Payal, Bowlby, Reanne, Brooks, Denise, Thiessen, Nina, Coarfa, Cristian, Ma, Yussanne, Moore, Richard A., Schein, Jacquie E., Mungall, Andrew J., Liu, Jinsong, Pecot, Chad V., Sood, Anil K., Jones, Steven J.M., Marra, Marco A., Gunaratne, Preethi H.
Publicado 2016

Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer

por Pan, Yinghong, Robertson, Gordon, Pedersen, Lykke, Lim, Emilia, Hernandez-Herrera, Anadulce, Rowat, Amy C., Patil, Sagar L., Chan, Clara K., Wen, Yunfei, Zhang, Xinna, Basu-Roy, Upal, Mansukhani, Alka, Chu, Andy, Sipahimalani, Payal, Bowlby, Reanne, Brooks, Denise, Thiessen, Nina, Coarfa, Cristian, Ma, Yussanne, Moore, Richard A., Schein, Jacquie E., Mungall, Andrew J., Liu, Jinsong, Pecot, Chad V., Sood, Anil K., Jones, Steven J.M., Marra, Marco A., Gunaratne, Preethi H.
Publicado 2017